16 research outputs found

    Case Report Near-Infrared Spectroscopy during the Verbal Fluency Task before and after Treatment with Image Exposure and SSRI Therapy in Patients with Obsessive-Compulsive Disorder

    No full text
    Drug therapy with selective serotonin reuptake inhibitors (SSRIs) has been used as a treatment for obsessive-compulsive disorder (OCD). In the present case report, exposure therapy was used in addition to escitalopram (20 mg) to treat a 28-year-old female patient with OCD for 6 months. Her obsessive-compulsive symptoms comprised thoughts of words such as rape, crematorium, neck hanging, unhappy, death, die, and kill and images such as a shelf of gods, a shrine, a Buddhist altar, the sun, the sky, and the faces of her parents, siblings, and relatives. As exposure therapy, she was asked to view the images associated with these symptoms three times a day along with drug therapy. With the combination of drug and exposure therapies, her obsessive-compulsive symptoms improved within 6 months, with no interference in her daily life. Multichannel near-infrared spectroscopy (NIRS) showed improvement of brain function in the temporal and frontal lobes after treatment. These results suggest that NIRS can be used as an indicator of brain function improvement in patients with OCD

    The comparative study of salivary alpha-amylase and salivary cortisol reaction to electric stimulation in avoidant personality disorder

    No full text
    Background : Avoidant personality disorder (AvPD) is a personality disorder recognized in the Diagnostic and Statistical Manual of Mental Disorders handbook (DSM-IV TR) in a person characterized by a pervasive pattern of social inhibition, feelings of inadequacy, extreme sensitivity to negative evaluation, and avoidance of social interaction. To this day, the causes of AvPD are not clearly defined, and may be influenced by a combination of social, genetic, and psychological factors. The disorder may be related to temperamental factors that are inherited. Moreover, the disorder may be related to the dysfunction of stress response systems. A role for hypothalamic-pituitary-adrenal (HPA)-axis activity in mediating stress responses has been intensively investigated for decades. Cortisol is an essential hormone in the regulation of stress response in the HPA axis, and salivary cortisol (sC) has been used as a simple, noninvasive index of free circulating cortisol levels. Recently, salivary alpha-amylase (sAA) has emerged as a new biomarker for responses to psychosocial stress within the sympathetic adrenomedullary (SAM) systems. To evaluate the effects of physical stress on HPA and SAM systems, we assessed the secretion of sAA and sC in AvPD patients and healthy volunteers after exposure to electric stimulation stress. Methods : Eleven AvPD patients with no psychiatric comorbidity (7 males and 4 females, aged 25.2±4.4) and 126 healthy volunteers with no history of psychiatric disorder (56 males and 70 females, aged 25.9±4.5) participated in this study. All subjects were exposed to electric stimulation stress with the stimulator coil on their wrists. Subjects were stimulated in incremental steps until they reached their threshold stimulus, defined as the greatest stimulus they could tolerate. The greatest stimulus lasted 40 seconds. To examine sAA and sC stress responses, we measured sAA and sC levels three times immediately before, immediately after, and 20 min after the intervention. We also determined State-Trait anxiety Inventory (STAI) scores and Profile of Mood State (POMS) scores of all subjects before the intervention. This study was approved by the Ethics Committee of Oita University. Written informed consent was obtained from all participants. Results : A significant sAA response to electric stimulation was found with peak values registered immediately after interventions in AvPD patients. However, we found no significant sAA response to electric stimulation in healthy controls. Moreover, AvPD patients always showed significantly higher sAA levels than healthy controls immediately before, immediately after, 20 min after the intervention. However, there was no significant difference in sC reactions between AvPD patients and healthy controls, and we found no significant sC response to electric stimulation in each group. The age, the proportion of males to females and the mean strength of electric stimulation in each group were statistically equal. STAI-Trait and STAI-State scores of AvPD patients were both greater than those of healthy controls. And POMS scores also showed greater subscales of tension-anxiety, depression, fatigue, confusion in AvPD patients than those of healthy patients. Conclusion : These preliminary results suggest that AvPD patients may be easily suffered from stronger feelings of tension-anxiety, depression, fatigue, and confusion compared to healthy people in stressful situation. Moreover, AvPD patients may react to stressors with SAM systems predominantly. The above indicates that the excessive acceleration of sympathetic nerves system may be related to the pathology of AvPD

    Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report

    No full text
    Background: Primary central nervous system lymphomas (PCNSLs) are sensitive to chemotherapy. The standard treatment is high-dose methotrexate (MTX)-based chemotherapy. There are no reports of successful treatment of acute uric acid nephropathy with rasburicase after MTX administration in PCNSLs. Case presentation: A 54-year-old man with a history of gout presented with a change in character and cognitive dysfunction. MRI showed a large enhancing mass spanning the bilateral frontal lobes and the right temporal lobe. After endoscopic biopsy, an MTX, procarbazine, and vincristine (MPV) regimen was initiated for the treatment of the PCNSL. After the initiation of chemotherapy, the patient experienced a gout attack, and blood examination revealed acute renal failure (ARF) and hyperuricemia. The considered causes of ARF included MTX toxicity and acute uric acid nephropathy. As the dramatic effect of MTX was observed, treatment was continued despite ARF, most probably due to acute hyperuricemia due to tumor lysis, which was treated in parallel. After an improvement in renal function, MTX was resumed, and rasburicase was initiated to control hyperuricemia. A complete response was obtained after induction chemotherapy. Hyperuricemia was controlled with rasburicase, and renal function was preserved. Conclusions: Acute uric acid nephropathy should be considered when ARF occurs after the initiation of MTX in PCNSLs, especially in newly diagnosed PCNSL patients with large tumors or hyperuricemia
    corecore